Japan College of Rheumatology
@JCRheum
Followers
323
Following
0
Media
18
Statuses
186
The Japan College of Rheumatology (JCR) is a medical society working to promote research, education and medical care on rheumatic diseases.
Joined January 2022
The call for abstracts is now open and will close at noon on Friday, October 31. We look forward to receiving many submissions! For details, please visit ourwebsite. https://t.co/265EFCj2FZ
#JCR2026 #TheJapanCollegeofRheumatology
0
1
0
Embargo Policy is now available on our website. https://t.co/265EFCj2FZ
#JCR2026 #TheJapanCollegeofRheumatology
0
1
0
Information for abstract submission and conflicts of interest is now available on our website. https://t.co/265EFCj2FZ
#JCR2026 #TheJapanCollegeofRheumatology
0
2
2
We have extended the early bird registration for #APLAR25 and it's now OPEN. Join APAC’s leading #rheumatology Congress in the historically rich city of #Fukuoka. Register before the extended deadline: 20 May 2025 Register here: https://t.co/qOEqAwxXWj
0
2
0
On-demand broadcast of Educational Lectures (Japanese) is now available. You can watch the lectures at My Page on the registration system. (Distribution period: May 1 (Thu), 2025, 5:00pm - May 30(Fri), 2025, noon) https://t.co/pPZuMzriaW
#JCR2025 #TheJapanCollegeofRheumatology
0
1
0
TS-1: Systemic Lupus Erythematosus and Autoimmune Rheumatic Disorders (2/2) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
Prof. Allan Gibofsky, who was scheduled to speak at the TREG session on Friday, April 25, is unable to attend due to illness. Dr. Kei Ikeda (Dokkyo Medical University) will be presenting in his behalf accordingly. (1/2) #JCR2025 #TheJapanCollegeofRheumatology
TREG Session: April 25,（Fri）8:45-10:45（Room 1, Concert Hall, 2F, Fukuoka Sunpalace） In this session, AI translator will be introduced, and the translation will be displayed in Japanese on the screen at the venue. #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
This year, we have “Minamiyamate Pudding” and “Castera (Japanese Sponge Cake) in Original Package” for you. We look forward to your participation! For more details, please check the JCR2025 website. (2/2) https://t.co/tqNENDbVCl…
#JCR2025 #TheJapanCollegeofRheumatology
0
1
0
Just like last year, we’ve prepared wonderful prizes that you can get based on the number of stamps you collected at the special exhibition booths. (1/2) #JCR2025 #TheJapanCollegeofRheumatology
1
1
2
Prof. Tanaka presents findings from the observational PROFILE-J study at JCR 2025, evaluating the safety of sarilumab in 1998 patients with rheumatoid arthritis and how patients reported improvements in their ability in active lives.(2/2) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
Apr. 25, 16:45-17:45 LBA3-6 Yoshiya Tanaka (The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) (1/2) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
Special talks by international opinion leaders about Overview, Inflammasomopathy, Type I interferonopathy, IL-18opathy, and Still’s disease are scheduled. (2/2) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
Symposium 21 (Planning by International Committee): The aim of this symposium is to understand autoinflammatory diseases. (1/2) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
It reveals how sarilumab can be used on its own and in combination with other drugs to treat 1998 Japanese patients with rheumatoid arthritis, including older patients. (2/2) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
16:45-17:45 LBA3-5 Yoshiya Tanaka (University of Occupational and Environmental Health, Japan) Prof. Yoshiya Tanaka presents findings at JCR 2025 from the year-long PROFILE-J study. (1/2) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
From data as of May 2023, incidence rates of AEs in the FIL200 and FIL100 group were analyzed, and no new safety concerns were found. (3/3) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
The post-hoc analysis of an integrated safety dataset of filgotinib (FIL) evaluated long-term safety up to 6 years in subgroup of Japanese patients with moderate-to-severe RA. (2/3) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
Apr. 25, 16:45-17:45 LBA3-4 Yoshiya Tanaka (The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) (1/3) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0
This symposium will introduce the latest findings by invited researchers from Japan and overseas. The basic language will be English with AI Translation implemented. We look forward to your attendance. (2/2) #JCR2025 #TheJapanCollegeofRheumatology
0
1
0
Symposium 9: To elucidate the pathomechanisms of systemic sclerosis (SSc), the comprehensive and single cell analysis, artificial intelligence (AI) has been proactively utilized. (1/2) #JCR2025 #TheJapanCollegeofRheumatology
1
1
0